| 1 |
35428708 | Tacrolimus in Patients With Interstitial Pneumonia Associated With Polymyositis or Dermatomyositis: Interim Report of Postmarketing Surveillance in Japan. | 2022 Apr 15 |
1 |
| 2 |
35578566 | Tacrolimus-Induced Neurotoxicity in Early Post-Liver Transplant Saudi Patients: Incidence and Risk Factors. | 2022 May 17 |
1 |
| 3 |
33149056 | Quantitation of Tacrolimus in Human Whole Blood Samples Using the MITRA Microsampling Device. | 2021 Jun 1 |
1 |
| 4 |
33853841 | Long-Term Immunosuppression Management: Opportunities and Uncertainties. | 2021 Aug |
1 |
| 5 |
33952632 | Tacrolimus Protects against Age-Associated Microstructural Changes in the Beagle Brain. | 2021 Jun 9 |
2 |
| 6 |
33963666 | Post-Liver Transplant Acute Kidney Injury. | 2021 Nov |
1 |
| 7 |
34085919 | Myelitis After Liver Transplant: A Case Report. | 2021 Jun 3 |
1 |
| 8 |
34150686 | Role of Tacrolimus C/D Ratio in the First Year After Pediatric Liver Transplantation. | 2021 |
2 |
| 9 |
34342024 | Effects and safety evaluation of Wuzhi Capsules combined with tacrolimus for the treatment of kidney transplantation recipients. | 2021 Dec |
2 |
| 10 |
34402788 | Current status of adverse event profile of tacrolimus in patients with solid organ transplantation from a pharmacovigilance study. | 2021 Dec |
1 |
| 11 |
34481645 | Calcineurin-Inhibitor Induced Pain Syndrome in a Heart Transplant Patient. | 2021 Oct |
1 |
| 12 |
34809463 | Leveraging Fungal and Human Calcineurin-Inhibitor Structures, Biophysical Data, and Dynamics To Design Selective and Nonimmunosuppressive FK506 Analogs. | 2021 Dec 21 |
1 |
| 13 |
31049814 | Efficacy and safety of tacrolimus and low-dose prednisone in Chinese children with steroid-resistant nephrotic syndrome. | 2020 Apr |
1 |
| 14 |
31386765 | Tacrolimus: 20 years of use in adult kidney transplantation. What we should know about its nephrotoxicity. | 2020 Feb |
2 |
| 15 |
31820394 | Clinical Pharmacokinetics and Impact of Hematocrit on Monitoring and Dosing of Tacrolimus Early After Heart and Lung Transplantation. | 2020 Apr |
1 |
| 16 |
32149187 | Tacrolimus-induced Diabetic Ketoacidosis in a Polymyositis Patient Precipitated by Fluconazole: A Case Report and Review of the Literature. | 2020 |
1 |
| 17 |
32307148 | Comparison of Kidney Transplant Function, Lipid Metabolism Disorders, and Glucose and Hemoglobin Concentration in Transplant Patients Treated With Proliferation Signal Inhibitor (Everolimus) or Calcineurin Inhibitor (Tacrolimus). | 2020 Oct |
2 |
| 18 |
32640952 | Immunosuppressive Management of Pediatric Kidney Transplant Recipients. | 2020 |
1 |
| 19 |
32664531 | Impacts of High Intra- and Inter-Individual Variability in Tacrolimus Pharmacokinetics and Fast Tacrolimus Metabolism on Outcomes of Solid Organ Transplant Recipients. | 2020 Jul 11 |
1 |
| 20 |
29479631 | Clinical aspects of tacrolimus use in paediatric renal transplant recipients. | 2019 Jan |
1 |
| 21 |
30371942 | Population Pharmacokinetics of Tacrolimus in Transplant Recipients: What Did We Learn About Sources of Interindividual Variabilities? | 2019 Mar |
1 |
| 22 |
30415182 | Calcineurin-inhibitor induced pain syndrome - Magnetic resonance imaging and scintigraphic findings illustrated through two cases. | 2019 Jan - Feb |
1 |
| 23 |
30983748 | Loss of Subpodocytic Space Predicts Poor Response to Tacrolimus in Steroid-Resistant Calcineurin Inhibitor-Naïve Adult-Onset Primary Focal Segmental Glomerulosclerosis. | 2019 Mar-Apr |
1 |
| 24 |
30983820 | Performance of tacrolimus in hospitalized patients with steroid-refractory acute severe ulcerative colitis. | 2019 Apr 7 |
1 |
| 25 |
31581670 | A Low Tacrolimus Concentration/Dose Ratio Increases the Risk for the Development of Acute Calcineurin Inhibitor-Induced Nephrotoxicity. | 2019 Oct 2 |
1 |
| 26 |
29298646 | Tacrolimus - Pharmacokinetic Considerations for Clinicians. | 2018 |
1 |
| 27 |
29594146 | Early Conversion from Tacrolimus to Belatacept in a Highly Sensitized Renal Allograft Recipient with Calcineurin Inhibitor-Induced de novo Post-Transplant Hemolytic Uremic Syndrome. | 2018 Jan-Apr |
1 |
| 28 |
29757021 | Advagraf® with or without an induction therapy for de novo kidney-transplant recipients. | 2018 Jun |
1 |
| 29 |
29904381 | The Calcineurin Inhibitor Tacrolimus Specifically Suppresses Human T Follicular Helper Cells. | 2018 |
2 |
| 30 |
30316389 | Dose-Response Relationship Between Diltiazem and Tacrolimus and Its Safety in Renal Transplant Recipients. | 2018 Oct |
1 |
| 31 |
28280692 | Influence of tacrolimus metabolism rate on renal function after solid organ transplantation. | 2017 Feb 24 |
2 |
| 32 |
28508247 | In human cell cultures, everolimus is inferior to tacrolimus in inhibiting cellular alloimmunity, but equally effective as regards humoral alloimmunity. | 2017 Sep |
1 |
| 33 |
29018183 | A Case of Left Renal Vein Ligation in a Patient with Solitary Left Kidney Undergoing Liver Transplantation to Control Splenorenal Shunt and Improve Portal Venous Flow. | 2017 Oct 11 |
1 |
| 34 |
29045960 | Pharmacokinetics of once daily prolonged-release formulation of tacrolimus in children with primary nephrotic syndrome. | 2017 Oct 18 |
2 |
| 35 |
26473523 | Evaluation of the Waters MassTrak LC-MS/MS Assay for Tacrolimus and a Comparison to the Abbott Architect Immunoassay. | 2016 Jun |
3 |
| 36 |
26663079 | Npas4 Transcription Factor Expression Is Regulated by Calcium Signaling Pathways and Prevents Tacrolimus-induced Cytotoxicity in Pancreatic Beta Cells. | 2016 Feb 5 |
1 |
| 37 |
26824445 | Immunosuppressive Medications and Squamous Cell Skin Carcinoma: Nested Case-Control Study Within the Skin Cancer after Organ Transplant (SCOT) Cohort. | 2016 Feb |
1 |
| 38 |
27003330 | Tacrolimus Concentration/Dose Ratio is Associated with Renal Function After Liver Transplantation. | 2016 Mar 22 |
1 |
| 39 |
27109969 | Meltdose Tacrolimus Pharmacokinetics. | 2016 Mar |
2 |
| 40 |
27462157 | Decreased calcineurin immunoreactivity in the postmortem brain of a patient with schizophrenia who had been prescribed the calcineurin inhibitor, tacrolimus, for leukemia. | 2016 |
1 |
| 41 |
27473149 | The phosphatase calcineurin regulates pathological TDP-43 phosphorylation. | 2016 Oct |
2 |
| 42 |
27500266 | Results of the TOP Study: Prospectively Randomized Multicenter Trial of an Ex Vivo Tacrolimus Rinse Before Transplantation in EDC Livers. | 2016 Jun |
1 |
| 43 |
25491283 | The calcineurin inhibitor tacrolimus as a new therapy in severe cherubism. | 2015 May |
1 |
| 44 |
25591474 | Effects of embryonic cyclosporine exposures on brain development and behavior. | 2015 Apr 1 |
1 |
| 45 |
25661468 | Anorexia nervosa in a pediatric renal transplant recipient and its reversal with cyclosporine. | 2015 May |
1 |
| 46 |
25883698 | Fungal infections in renal transplant patients. | 2015 Jun |
1 |
| 47 |
26031588 | Tacrolimus reduction with everolimus addition for calcineurin inhibitor-induced arteriolopathy in kidney allografts. | 2015 Jul |
2 |
| 48 |
26087255 | Differential Effects of Tacrolimus versus Sirolimus on the Proliferation, Activation and Differentiation of Human B Cells. | 2015 |
1 |
| 49 |
26160968 | Transplantation-Associated Thrombotic Microangiopathy in Patients Treated With Sirolimus and Cyclosporine as Salvage Therapy for Graft-Versus-Host Disease. | 2015 Sep |
1 |
| 50 |
26575262 | Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS. | 2015 Nov 8 |
1 |